Teva faces claims in Germany, Netherlands over EU abuse of MS drug
Teva Pharmaceuticals is the target of private litigation in Germany and the Netherlands as it contests an antitrust fine over its handling of multiple sclerosis drug Copaxone that drew sanctions from...To view the full article, register now.
Already a subscriber? Click here to view full article